Journals / Dicle Tıp Dergisi / 2008 / Cilt: 35 - Sayı: 1

Investigation of clinic and microbiologic effeects of systemic spiramycin application as adjunct to classic mechanic treatment of chronic periodontitis

Kronik periodontitisin klasik mekanik tedavisine ek olarak sistemik spiramisin uygulanımının klinik ve mikrobiyolojik etkilerinin incelenmesi

Pages
21–28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The evaluation of findings in this study shows a marked improvement in two groups for all indices and measurements, while the values of spiramycin groups were statistically significant when compared to the controls. (p<0.01)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, the cIinic and microbiologic effects of the systemic spiramycin administration as an adjunct to scaIing, root planining and curetage, on patients with chronicperiodontitis were investigated.
📊
Key Findings & Data:A total of 42 chronicpatients (15 women and 25 men, their age ranging between 35 to 65 with an average of 43.4) with chronicperiodontitis were included in this study.
💡
Conclusion & Impact:The evaluation of findings in this study shows a marked improvement in two groups for all indices and measurements, while the values of spiramycin groups were statistically significant when compared to the controls. (p<0.01)
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, the cIinic and microbiologic effects of the systemic spiramycin administration as an adjunct to scaIing, root planining and curetage, on patients with chronicperiodontitis were investigated. A total of 42 chronicpatients (15 women and 25 men, their age ranging between 35 to 65 with an average of 43.4) with chronicperiodontitis were included in this study. The patients were divided into the spiramycin and control groups.The scaling, root planining and curetage treatments were appIied to alI subjects. The application was combined with the use of 2 gr spiramycin a day for 2 weeks, where as antibacterial treatment was not appIied to the controls.The periodontal status of patients included in the study before and after therapy was evaluated. Using the indices, measurements and methods such as plaque index, gingival index, gingival bleeding time index, pocket depth measurement and microbiological investigations, together with t-test and ki- square tests. The evaluation of findings in this study shows a marked improvement in two groups for all indices and measurements, while the values of spiramycin groups were statistically significant when compared to the controls. (p<0.01)

Özet

Bu çalışmamızda, kronik periodontitisin tedavisinde diş taşı temizleme, kök yüzeyi düzleştirme ve subgingival küretaj işlemlerinin, sistemik spiramisin ile desteklenmesinin klinik ve mikrobiyolojik olarak etkinliği araştırılmıştır. Çalışmamıza yaşları 35 ile 65 arasında değişen ve yaş ortalaması 44.45 olan, 17'si kadın, 25'i erkek olan toplam 42 kronik periodontitisli hasta katıldı. Hastalar spiramisin uygulanan grup ile kontrol gruplarından birine yerleştirildi. Tüm bireylere diş taşı temizliği, kök yüzeyi düzleştirme ve küretaj işlemi uygulandı. Bu uygulama bir grupta 2 hafta boyunca günde 2 gr spiramisin ile desteklenirken, kontrol gurubu bireylerine antibakteriyel tedavi uygulanmadı. Araştırmaya katılan tüm hastaların tedavi öncesi ve tedavi sonrası periodontal durumları, plak indeksi, gingival indeks, dişeti kanama zamanı indeksi. Cep derinliği ölçümü ve mikrobiyolojik inceleme gibi indeks, ölçüm ve metotlarla t-testi ve ki-kare önemlilik testleri kullanılarak değerlendirildi. Araştırmadaki bulgularımızın değerlendirilmesi sonucunda tüm indeks ölçüm ve mikrobiyolojik incelemelerde, her iki grupta da beklenen iyileşme izlenirken, spiramisin grubu değerlerinin, kontrol grubu değerlerine oranla istatistiksel olarak bir üstünlük sağladığı görüldü (p<0.01).

🔖

Cite This Article

İPEK, F., GÜL, K. (2008). Investigation of clinic and microbiologic effeects of systemic spiramycin application as adjunct to classic mechanic treatment of chronic periodontitis. Dicle Tıp Dergisi, Cilt: 35 - Sayı: 1, 21–28. https://ajindex.com/articles/349250

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Grant DA, Stern IB, Listgarten MA. Perodontics. Sixth edition.The C. V. Mosby Company, Toronto, 1988
  2. Schluger S. Periodontal Diseases, London, 1990
  3. Genco RJ. Antibiotics in the treatment of human periodontal diseases. J. Periodontol. 1981; 52:545-558
  4. Listgarten MA. The role of dental plaque in gingivitis and periodontitis. J. Clin. Periodontol., 1988; 15:485-447
  5. Slots J. Bacterial specificity in chronicperiodontitis. J. Clin. Periodontol., 1986; 13:912-917.AI-Joburi W, Quee TC, Lautar C, Lugovaz İ, Bourgouin J, Delorme F, Chan, E.C.S. Effects of adjunctive treatment of periodontitis with tetracycline and spiramycin.J. Periodontol. 1989; 60: 101:533- 539
  6. Bain A, Beagrie GS, Bourgoın J, et all. The effects of spiramycin and/or scaling on advanced periodontitis in humans. J. Can. Dent. Assoc.,1994; 60:209, 212-217
  7. Ciancio C. Chemotherapeutic agents and periodontal therapy. J. Periodontol., 1986; 57: 108-111
  8. Rosling B, Slots J, Webber RL, Christersson LA, Genco, RJ. Microbiological and clinical effects of topical subgingival antimikrobiyal treatment on human periodontal disease. J. Clin. Periodontol. 1983;10:487-514
  9. Offenbacher S, Costopaulos SV, Odle BM, Van Dyke, T.E. Microbial colonization patterns of loosely adherent subgingival plaque in chronicperiodontitis. J. Clin. Periodontol. 1988; 15:53-59
  10. Descotes J, Vial T, Delattre D, Evreux JC. Spiramycin safety in man. J. Antimicrob. Chemot. 1988;22: 207-210
  11. Harvey RF. Clinical impressions of a new antibiotic in periodontics: Spiramycine. J. Can. Dent. Assoc. 1961;27: 576-85
  12. Mac-Farlane JA, Mitchell AB, Walsh MJ, Robertson JJ. Spiramycin in the prevention of post operative staphylococcal infection. Lancet 1968;1,1-4
  13. Vacek V. Spiramycin.Cas-Lek-Cesk., 1994; 17:55-60
  14. Freeman E. Periodontal disease part 3 Chemotherapeutics. Can. Fam. Physician.,. 1983;34:1395- 1397
  15. Quee TC. Spiramycin and the specific plaque hypothesis. J. Can. Dent. Assoc., 1982;, 2;121-127
  16. Quee TC, AI-Joburi W, Lautor-Lernay C, et al. Comparison of spiramycin and tetracycline used adjunctively in the treatment of advanced chronic periodontitis. J. Antimicrob. Chemot., 1988; 22.:171-177
  17. Lamy L, Landry RG, Roy S, La Spiramycine, J. Can. Dent. Assoc. 1989; 55;393-395
  18. Mills WH, Thompson GW, Beagrie, GS. Clinical evaluation of spiramycin and, erythromycin in control of periodontal diseas. J. Clin. Periodontol. 1979; 6;308-316 19. Laufer J, Mignon H, Videau D. L'assoc